P2X7 receptor positively regulates MyD88-dependent NF-κB activation

Cytokine

Volumn 55, Issue 2, 2011, Pages 229-236

  Liu, Yanhui ^a   Xiao, Yajuan ^a   Li, Zhiyuan ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

LPS; MyD88; NF B; P2X7 receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE; BETA INTERFERON; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; LUCIFERASE; MYELOID DIFFERENTIATION FACTOR 88; PURINERGIC P2X7 RECEPTOR; SMALL INTERFERING RNA; ZYMOSAN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOPRECIPITATION; IMMUNOREGULATION; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; GENE SILENCING; GENES, REPORTER; GOLGI APPARATUS; HEK293 CELLS; HUMANS; INTERFERON-BETA; MICE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; RECEPTORS, PURINERGIC P2X7; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 80955181114     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.003     Document Type: Article

References (33)

1. Surprenant A., North R.A. Signaling at purinergic P2X receptors. Annu Rev Physiol 2009, 71:333-359.
2. Chen L., Brosnan C.F. Regulation of immune response by P2X7 receptor. Crit Rev Immunol 2006, 26:499-513.
3. Ferrari D., et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006, 176:3877-3883.
4. Di Virgilio F. Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 2007, 28:465-472.
5. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511.
6. Iliev D.B., et al. Endotoxin recognition: in fish or not in fish?. FEBS Lett 2005, 579:6519-6528.
7. Donnelly-Roberts D.L., Jarvis M.F. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 2007, 151:571-579.
8. Ma P., et al. Toll-like receptors mediate induction of peptidoglycan recognition proteins in human corneal epithelial cells. Exp Eye Res 2010, 90:130-136.
9. Smart M.L., et al. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 2003, 278:8853-8860.
10. Denlinger L.C., et al. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 2001, 167:1871-1876.
11. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell 2006, 125:943-955.
12. Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004, 430:257-263.
13. Nishiya T., et al. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88. FEBS Lett 2007, 581:3223-3229.
14. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the toll signaling pathway. Nat Immunol 2001, 2:835-841.
15. Watts C. Location, location, location: identifying the neighborhoods of LPS signaling. Nat Immunol 2008, 9:343-345.
16. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007, 7:31-40.
17. Hsu L.C., et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA 2008, 105:7803-7808.
18. Guerra A.N., et al. Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J Endotoxin Res 2003, 9:256-263.
19. Ferrari D., et al. Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 1997, 139:1635-1643.
20. Korcok J., et al. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res 2004, 19:642-651.
21. Kim M., et al. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J 2001, 20:6347-6358.
22. Gu B.J., et al. The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood 2010, 115:1621-1631.
23. O'Neill L.A. How toll-like receptors signal: what we know and what we do not know. Curr Opin Immunol 2006, 18:3-9.
24. Budagian V., et al. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappaB. J Biol Chem 2003, 278:1549-1560.
25. Sedgwick S.G., Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 1999, 24:311-316.
26. Rubtsov A.M., Lopina O.D. Ankyrins. FEBS Lett 2000, 482:1-5.
27. Adriouch S., et al. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol 2002, 169:4108-4112.
28. Wiley J.S., et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 2003, 278:17108-17113.
29. Gu B.J., et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 2001, 276:11135-11142.
30. Shemon A.N., et al. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 2006, 281:2079-2086.
31. Gu B.J., et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 2004, 279:31287-31295.
32. Sluyter R., Shemon A.N., Wiley J.S. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol 2004, 172:3399-3405.
33. Adriouch S., et al. Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7. Purinergic Signal 2009, 5:151-161.